The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
APOLLO: A phase I study of adaptive memory natural killer (NK) cells in recurrent ovarian cancer.
 
Melissa Ann Geller
Honoraria - Boston Scientific
Research Funding - Bayer; FATE Therapeutics; Genentech; Morphotek; Ovagene Oncology; Tesaro
 
Sarah A. Cooley
Employment - Fate Therapeutics
Research Funding - Fate Therapeutics
Travel, Accommodations, Expenses - Fate Therapeutics
 
Mark Wallet
Employment - Fate Therapeutics
Stock and Other Ownership Interests - Fate Therapeutics
Patents, Royalties, Other Intellectual Property - Fate Therapeutics
 
Bahram Valamehr
Employment - Fate Therapeutics
Leadership - Fate Therapeutics
Stock and Other Ownership Interests - Fate Therapeutics
Research Funding - Fate Therapeutics
Patents, Royalties, Other Intellectual Property - Fate Therapeutics
 
Deanna Gek Koon Teoh
Research Funding - KCI; Tesaro
 
Todd E. DeFor
Stock and Other Ownership Interests - Medtronic
 
Martin Felices
Research Funding - Fate Therapeutics; GT Biopharma
Patents, Royalties, Other Intellectual Property - GT Biopharma
 
Jeffrey Miller
Stock and Other Ownership Interests - Fate Therapeutics; GT Biopharma
Honoraria - Nektar
Consulting or Advisory Role - Dr. Reddy's Laboratories; Fate Therapeutics; GT Biopharma; Nektar; Onkimmune
Research Funding - Fate Therapeutics (Inst); GT Biopharma (Inst)
Patents, Royalties, Other Intellectual Property - License IP Fate Therapeutics; License IP to GT Biopharma
Travel, Accommodations, Expenses - Dr. Reddy's Laboratories; Fate Therapeutics; GT Biopharma; Nektar; Nektar; Onkimmune